Miloš Grujić, Head of the Department of the Subspecialist Cabinets at the Center for Radiation Oncology at University Clinical Center Kragujevac, shared on LinkedIn:
“I am pleased to share our latest publication in Cancers MDPI.
Selected Blood-Accessible Biomarkers in Prostate Cancer Radiotherapy: A PRISMA-ScR Timing-Window Framework Beyond PSA
In this scoping review, we explored the current clinical evidence on blood-accessible biomarkers in prostate cancer radiotherapy and highlighted an often-overlooked aspect: the timing of blood sampling.
Our findings suggest that different biomarkers follow different biological kinetics, meaning that a single sampling schedule may not be appropriate for all biomarkers. We hope this work will contribute to more standardized biomarker research and support future studies in precision radiation oncology.
I would like to sincerely thank all my co-authors for their collaboration and valuable contributions.”
Authors: Miloš Grujić, Barbara Alicja Jereczek-Fossa, Ivan Jovanović, Marija Živković Radojević, Giulia Marvaso, Katarina Krasić, Katarina Janković, Marija Peulić, Federico Mastroleo, Łukasz Kuncman, Vladan Mutavdžić, Milica Mihajlović, Neda Milosavljević
More posts featuring Miloš Grujić.